Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1974-06-17
1976-01-13
Gotts, Lewis
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
424360, A61K 3700, C07C10352
Patent
active
039326241
ABSTRACT:
The angiotensin II inhibition by saralasin is prolonged by its subcutaneous administration in the form of a gel.
REFERENCES:
Goodman et al., "Pharmacological Basis of Therapeutics," 2nd Ed., MacMillan Co., New York, 1955, pp. 781-782.
Sollmann, "Manual of Pharmacology," 7th Ed., Saunders Co., Philadelphia, 1948, p. 56.
Brunner et al., Science, 174, 1344-1346 (1971).
Johnson et al., Chem. Abstr. 78:132114k (1973).
Pals et al., Chem. Abstr. 76:81495j (1972).
Franze Anthony J.
Gotts Lewis
Morton-Norwich Products, Inc.
Suyat Reginald J.
LandOfFree
Method for prolonging the inhibitory effect of saralasin on angi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for prolonging the inhibitory effect of saralasin on angi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for prolonging the inhibitory effect of saralasin on angi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-747993